Effect of Sugammadex Versus Neostigmine/Atropine Combination on Cognitive Function After Elective Adult Surgery

Trial Profile

Effect of Sugammadex Versus Neostigmine/Atropine Combination on Cognitive Function After Elective Adult Surgery

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2017

At a glance

  • Drugs Sugammadex (Primary) ; Neostigmine/atropine
  • Indications Cognition disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Sep 2017 Results published in the Anaesthesia and Intensive Care.
    • 29 Dec 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 20 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top